🇺🇸 NovoCure LtdNVCR

Investor Event Form 8-K 09-11-2026 06:59:49 EST

Subject: 8-K Items 7.01, 9.01

Overview: Received a Not Approvable Letter from the FDA regarding the Optune Mya Premarket Approval application for brain metastases from non-small cell lung cancer.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest